Released May 8, 2018, after the close
10-Q filed May 8, 2018, 38 days after period end · 0001162194-18-000055
Q1 2018 · 10-Q
Revenue$25.25M$25.25M −1.1% vs Q1 2017−9.0% vs Q4 2017
Net Income-$13.25M-$13.25M N/M vs Q1 2017N/M vs Q4 2017
EPS Diluted-$0.34-$0.34 N/M vs Q1 2017N/M vs Q4 2017
Gross Profit$13,428,000—
Operating Income-$12,633,000N/M
Operating Cash Flow-$16,176,000N/M
Free Cash Flowderived-$16,253,000N/M
Margins · derived
Gross margin53.2%
Operating margin-50.0%+18.6 pt vs Q1 2017
Net margin-52.5%+14.9 pt vs Q1 2017
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Revenue | $25.25M | $25.53M | $29.00M | $26.73M |
| Net Income | -$13.25M | -$17.20M | -$19.88M | -$15.93M |
| EPS Diluted | -$0.34 | -$0.59 | -$0.69 | -$0.56 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR